Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection
Open accessAbstract
Objective To investigate whether levothyroxine (LT4) treatment has beneficial effects on IVF results and pregnancy outcome in infertile patients with subclinical hypothyroidism undergoing IVF/intracytoplasmic sperm injection (ICSI). Design Prospective, randomized trial. Setting University-affiliated infertility clinic. Patient(s) A total of 64 infertile patients with subclinical hypothyroidism, defined as an elevated serum TSH level associated with a normal free T4 level and without frank symptoms of hypothyroidism. Intervention(s) Patients were randomized into an LT4 treatment group or control group. For the LT4 treatment group, 50 μg LT4 was administered from the first day of controlled ovarian stimulation for IVF/ICSI. Main outcome measure(s) Results of IVF and pregnancy outcome. Result(s) There were no differences in patient characteristics between the two groups. Total dose and days of recombinant human FSH used for controlled ovarian stimulation were also similar. The number of grade I or II embryos was significantly higher in the LT4 treatment group than in the control group. There was no significant difference in the clinical pregnancy rate per cycle between the two groups. However, the miscarriage rate was significantly lower in the LT4 treatment group than in the control group. Embryo implantation rate and live birth rate were significantly higher in the LT4 treatment group. In the control group, both thyroid peroxidase antibody and thyroglobulin antibody levels were significantly higher in the miscarried subgroup than in the delivered subgroup. Conclusion(s) LT4 treatment can improve embryo quality and pregnancy outcome in subclinical hypothyroid women undergoing IVF/ICSI.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is some limited evidence that progestin-only oral contraceptives increase the risk for later developing type 2 diabetes in women who have had gestational diabetes.
“however, there is some limited evidence that these medications increase the risk for later developing type 2 diabetes in women who have had gestational diabetes (222, 233).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [233]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942 · see citing works
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731 · see citing works
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567 · see citing works
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053 · see citing works
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561 · see citing works
Maraka, S., Singh Ospina, N. M., Mastorakos, G., & O’Keeffe, D. T. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00090 · Cited by 73 · see citing works
Benaglia, L., Busnelli, A., Somigliana, E., Leonardi, M., Vannucchi, G., De Leo, S., Fugazzola, L., Ragni, G., & Fedele, L. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.003 · Cited by 46 · see citing works
Dhillon‐Smith, R. K., Boelaert, K., Jeve, Y. B., Maheshwari, A., Coomarasamy, A., & Royal College of Obstetricians and Gynaecologists (2022) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17187 · Cited by 16 · see citing works
- Authors
- Kim, C.-H., Ahn, J.-W., Kang, S. P., Kim, S.-H., Chae, H.-D., & Kang, B.-M.
- Affiliations
- Asan Medical Center (KR)
- Corresponding author
- Kim, Chung-Hoon
- Kim, Sung-Hoon
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 95
- Issue
- 5
- Pages
- 1650-1654
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1978020454
- Cited by
- 172
- References
- 0
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 17 · 2020: 13 · 2019: 13 · 2018: 16 · 2017: 17 · 2016: 6 · 2015: 15 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- levothyroxine, subclinical hypothyroidism, in vitro fertilization, intracytoplasmic sperm injection, female infertility, embryo quality, pregnancy outcomes, miscarriage, thyroid peroxidase antibodies, thyroglobulin antibodies, controlled ovarian stimulation, live birth rate
- MeSH terms
- Abortion, Spontaneous, Adult, Female, Fertilization, Fertilization in Vitro, Humans, Hypothyroidism, Infertility, Female, Male, Pregnancy, Pregnancy Outcome, Thyroxine, Pregnancy Rate, Sperm Injections, Intracytoplasmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
